Aurinia Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
With a market cap of 2.16B, Aurinia Pharmaceuticals(AUPH) trades at $16.28. The stock has a price-to-earnings ratio of 29.01.
On 2025-12-25, Aurinia Pharmaceuticals(AUPH) stock traded between a low of $16.20 and a high of $16.42. Shares are currently priced at $16.28, which is +0.5% above the low and -0.9% below the high.
The Aurinia Pharmaceuticals(AUPH)'s current trading volume is 390.11K, compared to an average daily volume of 997.35K.
In the last year, Aurinia Pharmaceuticals(AUPH) shares hit a 52-week high of $16.54 and a 52-week low of $6.55.
In the last year, Aurinia Pharmaceuticals(AUPH) shares hit a 52-week high of $16.54 and a 52-week low of $6.55.
AUPH News
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But if you buy shares in a really...
